Clinical Trial

MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma

Study acronym: RADIANT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety and efficacy of embolization of the middle meningeal artery (MMA) using the NeoCast Embolic System for treatment of symptomatic subacute or chronic subdural hematoma (SDH) adjunctive to surgery.
Protocol Amendment History 4 changes
critical Primary endpoint(s) modified 2026-05-21
notable Enrollment increased: 150 -> 360 participants 2026-05-21
notable Primary completion pushed: 2027-11 -> 2028-01 2026-05-21
minor Completion pushed: 2028-02 -> 2028-04 2026-05-21
Trial Details
NCT Number NCT07541404
Lead Sponsor Arsenal Medical, Inc.
Conditions Subdural Hematoma
Enrollment 360 participants
Start Date 2026-07
Primary Completion 2028-01 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-20